Vext Science, Inc.
VEXTF
$0.1096
$0.00383.59%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 34.22M | 33.33M | 34.09M | 34.81M | 34.58M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 34.22M | 33.33M | 34.09M | 34.81M | 34.58M |
| Cost of Revenue | 25.50M | 25.77M | 25.42M | 22.77M | 20.06M |
| Gross Profit | 8.72M | 7.56M | 8.67M | 12.04M | 14.52M |
| SG&A Expenses | 16.09M | 15.78M | 13.66M | 13.89M | 8.47M |
| Depreciation & Amortization | 8.58M | 8.16M | 6.95M | 6.04M | 5.33M |
| Other Operating Expenses | -1.00K | -7.00K | -13.00K | -19.00K | -18.00K |
| Total Operating Expenses | 50.16M | 49.70M | 46.02M | 42.68M | 33.85M |
| Operating Income | -15.94M | -16.37M | -11.93M | -7.87M | 726.60K |
| Income Before Tax | -5.99M | -6.15M | -2.24M | 3.36M | -4.50M |
| Income Tax Expenses | 1.60M | 778.70K | -235.20K | -1.04M | -9.56M |
| Earnings from Continuing Operations | -7.59 | -6.93 | -2.01 | 4.40 | 5.06 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.59M | -6.93M | -2.01M | 4.40M | 5.06M |
| EBIT | -15.94M | -16.37M | -11.93M | -7.87M | 726.60K |
| EBITDA | -1.70M | -3.42M | -800.40K | 1.64M | 8.38M |
| EPS Basic | -0.03 | -0.03 | -0.01 | 0.02 | 0.04 |
| Normalized Basic EPS | -0.04 | -0.05 | -0.04 | -0.03 | -0.01 |
| EPS Diluted | -0.03 | -0.03 | -0.01 | 0.02 | 0.04 |
| Normalized Diluted EPS | -0.04 | -0.05 | -0.04 | -0.03 | -0.01 |
| Average Basic Shares Outstanding | 925.27M | 829.48M | 733.76M | 658.14M | 589.92M |
| Average Diluted Shares Outstanding | 928.87M | 829.98M | 734.63M | 659.01M | 590.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
